Chemdex
This article was originally published in The Gray Sheet
Executive Summary
Business-to-business life sciences e-commerce firm completes $1.3 bil. acquisition of medical device Web-based auction company Promedix, Chemdex says Feb. 11. Chemdex will exchange an estimated 12 mil. shares of its common stock for all outstanding Promedix shares, options and warrants under the purchase transaction. Promedix spins off specialty medical product distribution business, which is not part of the deal. Separately, Chemdex finalizes purchase of all shares, options and warrants of privately-held SpecialtyMD.com in exchange for 1.25 mil. shares of Chemdex common stock. At Chemdex' Feb. 10 closing value of 105-3/8, the transaction is valued at approximately $132 mil. SpecialtyMD.com offers clinical and product content to clinicians and purchasing professionals